Back
Politics

Victoria Expands Pharmacy Access for Contraceptive Pill and Other Health Treatments

View source

Victorian Government Expands Pharmacy Access for Contraceptive Pill

The Victorian government has announced that women over 18 will be able to access the contraceptive pill for the first time from participating pharmacies without a prescription starting in July. This decision has drawn criticism from general practitioners.

Expanded Access and Scheme Details

Starting in July, the contraceptive pill will be available through 850 pharmacies participating in the Chemist Care Now scheme. This initiative, which began as a pilot in 2023, previously allowed women to obtain repeat prescriptions for the pill without a doctor's visit. Its expansion now includes hormone replacement therapy, travel vaccinations, and treatments for conditions such as shingles and uncomplicated urinary tract infections (UTIs), many of which previously required a doctor's appointment.

Premier Jacinta Allan stated that the initiative aims to reduce costs for women, emphasizing that:

"Accessing contraception should not be a burden for women."

Health Minister Mary-Anne Thomas added that:

The measure provides women with more choice and convenience.

General Practitioners Raise Concerns

The Royal Australian College of GPs (RACGP) criticized the expansion, asserting that it undermines established safeguards and Therapeutic Goods Administration (TGA) assessments. Dr. Anita Muñoz of the RACGP noted that a recent TGA review indicated the contraceptive pill should only be prescribed by a medical practitioner. Dr. Muñoz expressed concern that the Victorian government's decision contradicts this advice.

She highlighted several critical risk factors that require screening before prescribing the pill, including high blood pressure, body mass index, liver disease, and migraine disorders. Dr. Muñoz also stated that GPs engage patients in broader discussions regarding sexual health, sexually transmitted infections, safe relationships, and intimate partner violence, which she believes are not feasible in a retail pharmacy setting.

Furthermore, Dr. Muñoz mentioned Australia's low uptake of long-acting reversible contraception (LARC) compared to other OECD countries. She suggested that these options should also be presented to women, given that a significant percentage of abortions are attributed to oral contraceptive pill failures.

The Pharmacy Guild's Perspective

Grace Chong from the Pharmacy Guild of Australia stated that the initiative would improve health outcomes for women. She believes it allows immediate consultations with pharmacists about contraceptive options, rather than requiring women to wait for GP appointments.

The initiative would improve health outcomes for women by allowing immediate consultations with pharmacists about contraceptive options, rather than requiring women to wait for GP appointments.

Chong cited an example of a recent interaction where a woman sought advice on different pill options after several years without specialist consultation. She affirmed that pharmacists will collaborate with local GPs to ensure women receive appropriate contraception.

Consultations with pharmacists for the pill will be free, though the product itself will incur a cost. Pharmacists providing this service must complete a postgraduate training module for accreditation and will also advise on other contraceptive methods, including LARC.

Results from the Pilot Program

The government reported that during the trial phase of the scheme, 17,000 women accessed resupply of the contraceptive pill.